Drugs / sodium selenite pentahydrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04201561 | Dec 2019 → Apr 2023 | chemotherapy-induced neuropathy, fallopian tube cancer, ovarian carcinoma, primary peritoneal carcinoma | Seoul National University Hospital | Unknown | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium selenite pentahydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04201561 ↗ |